Bal Pharma Limited has informed the Exchange regarding Corrigendum to the notice for the board meeting issued on 18.05.2026
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bal Pharma Limited has issued an addendum to its board meeting notice originally dated May 18, 2026. The board meeting scheduled for May 27, 2026 will now also consider approval for fund raising through preferential issue of warrants to promoters. All other agenda items from the earlier notice remain unchanged. The specific amount to be raised and other terms of the warrant issue are not disclosed in this filing.
Preferential issuance of warrants to promoters typically leads to equity dilution for existing shareholders when warrants are exercised. This suggests the promoters are participating in funding the company's growth, which could be viewed as a sign of promoter confidence but may impact minority shareholder stakes.